论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
利用甲磺酸伊马替尼作为新辅助治疗和辅助治疗手段治疗原发性胃肠道间质瘤:病例报告和文献回顾
Authors Shen H, Wang Z, Feng M, Liu J, Li J, Wang X, Xu X
Received 8 October 2019
Accepted for publication 16 December 2019
Published 30 December 2019 Volume 2019:12 Pages 11549—11553
DOI https://doi.org/10.2147/OTT.S233868
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Geoffrey Pietersz
Abstract: The current study presents a case of primary prostatic extra-gastrointestinal stromal tumor (EGIST) in a 43-year-old man who suffered acute urinary retention. The serum level of prostate-specific antigen was normal. Imaging examinations demonstrated a diffusely enlarged prostate compressing the rectum without evidence of metastasis. After excluding the possibility of secondary involvement by a rectal GIST, the pathologic diagnosis of primary prostatic EGIST was established based on microscopic study, immunohistochemistry, and molecular analysis. This patient is the first case with primary EGISTs of prostate received imatinib mesylate as neoadjuvant and adjuvant therapy reported in the literature to date. We hope this case could provide the experience of diagnosis and treatment of primary prostatic EGISTs.
Keywords: extra-gastrointestinal stromal tumor, EGIST, prostate, imatinib mesylate
